|
|
|
| Antimicrobial activity of tannic acid and its effect on biofilms of clinical isolates |
1.School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, 325035; 2.Department of Laboratory Medicine, the Frist Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325015
|
|
| Cite this article: |
|
YU Xiao1,HOU Yuanbo1,ZHOU Tieli2, et al. Antimicrobial activity of tannic acid and its effect on biofilms of clinical isolates[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2015, 45(10 ): 709-.
|
|
|
Abstract Objective: To analyze the antimicrobial activity of tannic acid against clinical isolates and its effect on biofilms. Methods: Nine kinds of common clinical isolates, including Staphylococcus aureus, Staphylococcus epidermidis, Hemolytic staphylococci, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii were collected. All kinds of antimicrobial agents were evaluated with agar dilution method for the minimal inhibitory concentrations (MIC). According to the results of susceptibility testing, 9 kinds of clinical isolates were divided into multidrug-resistant (MDR) group or non-multidrug-resistant group (nMDR). Thirty strains from each group were randomly selected as experimental strains. Agar dilution method was used to detect tannic acid MIC of the strain. The difference of the 2 groups to reflect the tannic acid antibacterial activities of common clinical isolates was compared. The effect on the biofilm formation was detected by adding tannic acid into the biofilm culture medium. Results: Tannic acid showed strong antibacterial activity to the 9 kinds of clinical isolates, antibacterial activity to the Staphylothermus bacteria was significantly greater than those for the other bacteria (P<0.05). Tannic acid could inhibit the bacterial biofilm formation. Conclusion: Tannic acid has antibacterial effect to common clinical isolates and can influence the formation of biofilm.
|
|
Received: 30 March 2015
|
| |
|
|
|
[1] Colatrella S, Clair JD. Adapt or perish — a relentless fight for survival: designing superbugs out of the intensive care unit[J]. Crit Care Nurs Q, 2014, 37(3): 251-256.
[2] Xu ZQ, Flavin MT, Flavin J, et al. Combating multidrug-re sistant Gram-negative bacterial infections[J]. Expert Opin Investig Drugs, 2014, 23(2): 163-168.
[3] 张永军, 邱娟, 江涵, 等. 复方儿茶软膏安全性评价及初步药理研究[J]. 中国医院药学杂志, 2011, 31(3): 207-211.
[4] 谢倩, 李继遥, 左渝陵, 等. 天然药物五倍子提取物对致龋茵生长的影响[J]. 华西口腔医学杂志, 2005, 23(1): 82-86.
[5] Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty- fourth informational supplement[S]. Wayne, Pa: Clinical and Laboratory Standards Institute, 2014.
[6] Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance[J]. Clin Microbiol Infect, 2012, 18(3): 268-272.
[7] Asencio MA, Carranza R, Huertas M, et al. Antimicrobial resistance of the most frequently isolated microorganisms in the Hospital General La Mancha Centro between June
2009 and May 2010[J]. Rev Esp Quimioter, 2012, 25(3): 183-186.
[8] Xu ZQ, Flavin MT, Flavin J, et al. Combating multidrug-resistant Gram-negative bacterial infections[J]. Expert Opin Investig Drugs, 2014, 23(2): 163-167.
[9] Payne DE, Martin NR, Parzych KR, et al. Tannic acid inhib its staphylococcus aureus surface colonization in an isaA-dependent manner[J]. Infect Immun, 2013, 81(2): 496-504.
[10] Costerton JW, Stewart PS, Greenberg EP, et al. Bacterial biofims: a common cause ofpersistent infections[J]. Science, 1999, 284(1): 1318-1321. |
|
|
|
